Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
2025 · Cancer Cell · 33 citations
https://doi.org/10.1016/j.ccell.2025.02.010
C
Cecilia Monge
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
1.3K
Citations
14
h-index
19
i10-index
Cecilia Monge is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 14, co-authored 51 publications.
ORCID: 0000-0002-5558-2744Papers by this author
worksTumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
2023 · Cell Reports Medicine · 29 citations
https://doi.org/10.1016/j.xcrm.2023.101052
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years
2023 · Cancer Medicine · 21 citations
https://doi.org/10.1002/cam4.6814
Detecting <scp>PI3K</scp> and <scp>TP53</scp> Pathway Disruptions in Early‐Onset Colorectal Cancer Among Hispanic/Latino Patients
2025 · Cancer Medicine · 18 citations
https://doi.org/10.1002/cam4.70791
Lineage and ecology define liver tumor evolution in response to treatment
2024 · Cell Reports Medicine · 9 citations
https://doi.org/10.1016/j.xcrm.2024.101394
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
2025 · The Lancet Regional Health - Europe · 4 citations
https://doi.org/10.1016/j.lanepe.2025.101408
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat